Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Phase I/Randomized Phase II Double Blind Study of Either Dasatinib or Placebo Combined With Bevacizumab in Recurrent Glioblastoma
Status: Enrolling
Updated:  8/11/2016
Fredericksburg Oncology, Incorporated
mi
from
Fredericksburg, VA
Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Phase I/Randomized Phase II Double Blind Study of Either Dasatinib or Placebo Combined With Bevacizumab in Recurrent Glioblastoma
Status: Enrolling
Updated: 8/11/2016
Fredericksburg Oncology, Incorporated
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated:  8/16/2016
Ann & Robert H. Lurie Children's Hospital of Chicago Dept of Oncology
mi
from
Chicago, IL
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated: 8/16/2016
Ann & Robert H. Lurie Children's Hospital of Chicago Dept of Oncology
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated:  8/16/2016
Children's Hospital of Pittsburgh Dept of Oncology
mi
from
Pittsburgh, PA
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated: 8/16/2016
Children's Hospital of Pittsburgh Dept of Oncology
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated:  8/16/2016
Cincinnati Children's Hospital Medical Center Division of Hema/Onco.
mi
from
Cincinnati, OH
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated: 8/16/2016
Cincinnati Children's Hospital Medical Center Division of Hema/Onco.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated:  8/16/2016
Columbia University Medical Center- New York Presbyterian Dept of Oncology
mi
from
New York, NY
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated: 8/16/2016
Columbia University Medical Center- New York Presbyterian Dept of Oncology
mi
from
New York, NY
Click here to add this to my saved trials
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated:  8/16/2016
Dana Farber Cancer Institute SC-7
mi
from
Boston, MA
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated: 8/16/2016
Dana Farber Cancer Institute SC-7
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated:  8/16/2016
Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Dept Onc
mi
from
Baltimore, MD
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated: 8/16/2016
Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Dept Onc
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated:  8/16/2016
University of Texas/MD Anderson Cancer Center SC-3
mi
from
Houston, TX
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated: 8/16/2016
University of Texas/MD Anderson Cancer Center SC-3
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated:  8/16/2016
Seattle Cancer Care Alliance Dept of Oncology
mi
from
Seattle, WA
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated: 8/16/2016
Seattle Cancer Care Alliance Dept of Oncology
mi
from
Seattle, WA
Click here to add this to my saved trials
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated:  8/16/2016
Novartis Investigative Site
mi
from
Herston,
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma
Status: Enrolling
Updated: 8/16/2016
Novartis Investigative Site
mi
from
Herston,
Click here to add this to my saved trials
Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases
A Phase I Trial of Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases
Status: Enrolling
Updated:  8/18/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases
A Phase I Trial of Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases
Status: Enrolling
Updated: 8/18/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated:  10/21/2016
Baylor University Medical Center
mi
from
Dallas, TX
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated: 10/21/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated:  10/21/2016
Aurora BayCare Medical Center
mi
from
Green Bay, WI
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated: 10/21/2016
Aurora BayCare Medical Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated:  10/21/2016
Saint Lukes Hospital
mi
from
Kansas City, MO
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated: 10/21/2016
Saint Lukes Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated:  10/21/2016
Washington University
mi
from
Saint Louis, MO
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated: 10/21/2016
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Tucson, AZ
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Berkeley, CA
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Berkeley, CA
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
San Francisco, CA
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Aurora, CO
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Newark, DE
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Newark, DE
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Tampa, FL
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Atlanta, GA
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Honolulu, HI
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Chicago, IL
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Peoria, IL
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Peoria, IL
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Iowa City, IA
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Kansas City, KA
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Baltimore, MD
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Bethesda, MD
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Boston, MA
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Detroit, MI
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Rochester, MN
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Columbia, MO
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Columbia, MO
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
St Louis, MO
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Omaha, NE
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Lebanon, NH
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Santa Fe, NM
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Buffalo, NY
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
New York, NY
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Columbus, OH
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Memphis, TN
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Nashville, TN
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Dallas, TX
Enzastaurin Versus Lomustine in Glioblastoma
Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials